The 3rd  Microbiome Movement – Maternal & Infant Health Summit will return May 2021

The 2nd Microbiome Movement – Maternal & Infant Health Summit returns as the only conference to unite large pharma, drug developers, academic KOL’s and paediatric clinicians to discuss the shared challenges of helping to configure the microbiome in the first 1000 days of life to reduce risk of chronic health conditions.

With a global rise of incidence of allergies and childhood onset metabolic disorders, the first 1000 days of life represents a key window of opportunity to create products and solutions that target the infant microbiome to prevent the onset of these chronic health conditions.

Join the leaders from the maternal-infant microbiome space as they present the latest data-driven research and discuss how to shape future research to accelerate the field as we begin to unlock the secrets of the infant microbiome to proactively prevent disease.

Our 2020 Speaker Faculty

David Kyle

Chairman & CEO

Evolve Biosystems, Chair

Chris Damman

Senior Program Officer, Global Health

Bill & Melinda Gates Foundation

Georg Gerber

Assistant Professor of Pathology

Brigham & Women’s Hospital

Meghan Azad

Assistant Professor, Pediatrics and Child Health

University of Manitoba

Richard Insel

Global Head, Healthy Baby Initiative

Johnson & Johnson

Alessio Fasano

Chief, Pediatric Gastroenterology & Nutrition

Massachusetts General Hospital

Olga Sakwinska

Senior Scientist

Nestlé Research

Padmaja Subbarao

Director, CHILD Cohort Study

University of Toronto & McMaster University

2020 Partners

Events In The Microbiome Movement Series